Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Studies have found that the high-dose influenza vaccine has a higher relative vaccine effectiveness (RVE) versus standard-dose vaccines in some seasons. We evaluated the effect of age on the RVE of high-dose versus standard-dose influenza vaccines among Medicare beneficiaries.
Methods: A 6-season retrospective cohort study from 2012 to 2018 among Medicare beneficiaries aged ≥65 years was performed. Poisson regression was used to evaluate the effect of age on the RVE of high-dose versus standard-dose influenza vaccines in preventing influenza-related hospitalizations.
Results: The study included >19 million vaccinated beneficiaries in a community pharmacy setting. The Poisson models indicated a slightly increasing trend in RVE with age in all seasons. The high-dose vaccine was more effective than standard-dose vaccines in preventing influenza-related hospital encounters (ie, influenza-related inpatient stays and emergency department visits) in the 2012-2013 (RVE, 23.1%; 95% confidence interval [CI], 17.6%-28.3%), 2013-2014 (RVE, 15.3%; 95% CI, 7.8%-22.3%), 2014-2015 (RVE, 8.9%; 95% CI, 5.6%-12.1%), and 2016-2017 (RVE, 12.6%; 95% CI, 6.3%-18.4%) seasons and was at least as effective in all other seasons. We also found that the high-dose vaccine was consistently more effective than standard-dose vaccines across all seasons for people aged ≥85 years. Similar trends were observed for influenza-related inpatient stays.
Conclusions: The RVE of high-dose versus standard-dose influenza vaccines increases with age.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/infdis/jiz360 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Evaluation of the Infant Skull via Low-dose CT Images Using an Sn Filter and the Iterative Reconstruction Method].
Nihon Hoshasen Gijutsu Gakkai Zasshi
September 2025
Division of Neonatology, Maternal and Perinatal Center, Toyama University Hospital.
Purpose: This study aimed to evaluate whether low-dose CT imaging using an Sn filter can provide image quality sufficient for the differential diagnosis of cranial deformities in infants while maintaining an effective dose comparable to that of conventional radiography.
Methods: We calculated the effective dose for both head X-ray imaging and low-dose CT with an Sn filter. Phantom images acquired using a CT scanner equipped with an Sn filter were evaluated for bone suture visibility at various conditions (from 10 mAs to 50 mAs, every 10 mAs) using a 4-point visual grading scale.
Analysis of standard vs dose-escalated stereotactic body radiation therapy in localized prostate cancer: a comparative evaluation of survival outcomes.
Front Immunol
August 2025
Department of Radiation Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
Background And Purpose: This study aimed to compare the safety and efficacy of high-dose biologically effective dose (BED) versus standard dose regimens in stereotactic body radiotherapy (SBRT) for localized prostate cancer (PCa) using a propensity score matching (PSM) analysis.
Methods: Between June 2012 and February 2022, prostate-localized SBRT patients from two institutions were retrospectively reviewed. The high-dose group (n=12) received high-dose BED (>250Gy), and the control group (n=119) according to NCCN guidelines (35-37.
Efficacy and safety of a reduced starting dose of cabozantinib (20 mg) plus nivolumab for renal cell carcinoma in real-world practice.
Jpn J Clin Oncol
August 2025
Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
Background: In systemic treatment for renal cell carcinoma, some patients require dose reduction to prevent adverse events. However, there is currently almost no evidence to support a reduced starting dose for cabozantinib + nivolumab (C + N) in clinical practice.
Methods: We retrospectively analyzed single-institution data for patients with renal cell carcinoma with an assessed response to C + N.
Application and Outcomes of Minimal-Dose Versus Standard-Dose Radiation in Peripheral Endovascular Intervention (KAR Endovascular Study).
J Cardiovasc Dev Dis
July 2025
Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX 79905, USA.
Background: Peripheral endovascular intervention (PEVI) is routinely performed using standard-dose radiation (SDR), which is associated with elevated levels of radiation. No study has evaluated the outcomes of minimal-dose radiation (MDR) in PEVI.
Methods: We performed a prospective observational study of 184 patients (65 ± 12 years) at an academic medical center from January 2019 to March 2020 (mean follow-up of 3.
The impact of standard- versus reduced-dose tacrolimus exposure on clinical outcomes in adult kidney transplant recipients: A systematic review and meta-analysis.
Transplant Rev (Orlando)
July 2025
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
Concerns around calcineurin inhibitor-induced nephrotoxicity after kidney transplantation have led to dose-reduction practices. However, "reduced dose" remains poorly defined, and evidence comparing outcomes for standard- versus reduced-dose tacrolimus trough concentration (C) above 5 ng/mL is limited. We searched multiple electronic databases (Jan 1, 2000-June 30, 2024) for randomized controlled or observational studies that reported clinical outcomes (acute rejection, nephrotoxicity, graft survival, patient survival, and estimated glomerular filtration rate) directly against tacrolimus C as an independent clinical variable in adult kidney transplant recipients who received tacrolimus.
View Article and Find Full Text PDF